InsidersTradesSigma
Follow the BioArctic AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, BioArctic AB has logged 0 insider filings. Market capitalisation: €27.1bn. All data is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioArctic AB Hold (neutral), based on 5 analysts. Average price target: SEK 301.40.
Fundamental score
Ranked 5,362 of 29,065 companies
67.8
score / 100
Value47
Quality88
FCF yld5.0%
Earn yld3.6%
EV/EBITDA22.4x
ROE10%
Gross mgn97%
Net mgn51%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About BioArctic AB
BioArctic AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).